{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:44:51Z","timestamp":1794739491428,"version":"4.9.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.eclinm.2026.103926","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:36:39Z","timestamp":1777602999000},"page":"103926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Histotripsy for liver tumours: a systematic review and meta-analysis of current clinical evidence"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9275-4744","authenticated-orcid":false,"given":"Chase J.","family":"Wehrle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3548-648X","authenticated-orcid":false,"given":"Joshua","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9994-6303","authenticated-orcid":false,"given":"Ahmed Sayed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8843-6959","authenticated-orcid":false,"given":"Syed Imad","family":"Ul Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Aucejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar A.","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Silk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.H.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6556-3830","authenticated-orcid":false,"given":"D. Brock","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.eclinm.2026.103926_bib1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103926_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10.1016\/j.eclinm.2026.103926_bib3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5306\/wjco.v11.i10.761","article-title":"Colorectal liver metastases: current management and future perspectives","volume":"11","author":"Martin","year":"2020","journal-title":"World J Clin Oncol"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103926_bib4","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jama.2025.25467","article-title":"Leading cancer deaths in people younger than 50 years","volume":"335","author":"Siegel","year":"2026","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103926_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101567","article-title":"The management of hepatocellular carcinoma. current expert opinion and recommendations derived from the 24th ESMO\/World Congress on Gastrointestinal Cancer, Barcelona, 2022","volume":"8","author":"Ducreux","year":"2023","journal-title":"ESMO Open"},{"issue":"41","key":"10.1016\/j.eclinm.2026.103926_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1200\/EDBK_320519","article-title":"Locoregional therapies for colorectal cancer liver metastases: options beyond resection","volume":"41","author":"Uhlig","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.eclinm.2026.103926_bib7","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.ejso.2007.09.017","article-title":"Bringing unresectable liver disease to resection with curative intent","volume":"33","author":"Wicherts","year":"2007","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103926_bib8","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s11605-023-05723-8","article-title":"Liquid biopsy by ctDNA in liver transplantation for colorectal cancer liver metastasis","volume":"27","author":"Wehrle","year":"2023","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.eclinm.2026.103926_bib9","doi-asserted-by":"crossref","first-page":"e2300111","DOI":"10.1200\/CCI.23.00111","article-title":"Circulating tumor DNA in colorectal cancer liver metastasis: analysis of patients receiving liver resection and transplant","volume":"7","author":"Wehrle","year":"2023","journal-title":"JCO Clin Cancer Inform"},{"issue":"8","key":"10.1016\/j.eclinm.2026.103926_bib10","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3390\/cancers16081453","article-title":"Emerging and clinically accepted biomarkers for hepatocellular carcinoma","volume":"16","author":"Fares","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103926_bib11","doi-asserted-by":"crossref","first-page":"e2454707","DOI":"10.1001\/jamanetworkopen.2024.54707","article-title":"Estimated burden of metabolic dysfunction\u2013associated steatotic liver disease in US adults, 2020 to 2050","volume":"8","author":"Le","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103926_bib12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1186\/s12885-018-4716-8","article-title":"Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial","volume":"18","author":"Puijk","year":"2018","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.eclinm.2026.103926_bib13","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/LVT.0000000000000417","article-title":"Intensive locoregional therapy before liver transplantation for colorectal cancer liver metastasis: a novel pretransplant protocol","volume":"30","author":"Wehrle","year":"2024","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103926_bib14","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1097\/JS9.0000000000004018","article-title":"Liver transplantation for colorectal metastasis - selection criteria, outcomes, and management recurrence: a systematic review and meta-analysis","volume":"112","author":"Sayed Ahmed","year":"2026","journal-title":"Int J Surg"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103926_bib15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/SLA.0000000000003253","article-title":"Pathologic response to pretransplant locoregional therapy is predictive of patient outcome after liver transplantation for hepatocellular carcinoma: analysis from the US multicenter HCC transplant consortium","volume":"271","author":"DiNorcia","year":"2020","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103926_bib16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jhep.2024.09.003","article-title":"Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: the multicenter VITALITY study","volume":"82","author":"Tabrizian","year":"2025","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.eclinm.2026.103926_bib17","first-page":"779","article-title":"Ten-year outcomes of liver transplant and downstaging for hepatocellular carcinoma","volume":"157","author":"Tabrizian","year":"2022","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103926_bib18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.21037\/hbsn-23-677","article-title":"Radiofrequency ablation versus microwave ablation for colorectal liver metastases: long-term results of a retrospective cohort surgical experience","volume":"13","author":"Sarioglu","year":"2024","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"21","key":"10.1016\/j.eclinm.2026.103926_bib19","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.3390\/cancers13215558","article-title":"Locoregional treatments for bridging and downstaging HCC to liver transplantation","volume":"13","author":"Crocetti","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"21","key":"10.1016\/j.eclinm.2026.103926_bib20","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.3390\/cancers15215220","article-title":"Immunotherapy plus locoregional therapy leading to curative-intent hepatectomy in HCC: proof of concept producing durable survival benefits detectable with liquid biopsy","volume":"15","author":"Raj","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103926_bib21","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.rcl.2015.05.012","article-title":"Liver ablation: best practice","volume":"53","author":"Wells","year":"2015","journal-title":"Radiol Clin North Am"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103926_bib22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1148\/radiol.2015142489","article-title":"Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting Outcomes--A 10-year experience at a single center","volume":"278","author":"Shady","year":"2016","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103926_bib23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103926_bib24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","article-title":"Hepatobiliary cancers, version 2.2021, NCCN clinical Practice Guidelines in oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103926_bib25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jhep.2017.02.022","article-title":"Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis","volume":"67","author":"Sapisochin","year":"2017","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103926_bib26","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233051","article-title":"The #HOPE4LIVER single-arm pivotal trial for histotripsy of primary and metastatic liver tumors","volume":"312","author":"Mendiratta-Lala","year":"2024","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103926_bib27","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/02656736.2022.2112309","article-title":"First-in-man histotripsy of hepatic tumors: the THERESA trial, a feasibility study","volume":"39","author":"Vidal-Jove","year":"2022","journal-title":"Int J Hyperthermia"},{"issue":"8","key":"10.1016\/j.eclinm.2026.103926_bib28","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.gassur.2024.05.038","article-title":"Histotripsy - hype or hope? Review of innovation and future implications","volume":"28","author":"Sandilos","year":"2024","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103926_bib29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0022-5347(05)00141-2","article-title":"Pulsed cavitational ultrasound: a noninvasive technology for controlled tissue ablation (histotripsy) in the rabbit kidney","volume":"175","author":"Roberts","year":"2006","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103926_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1121\/1.2735110","article-title":"Effects of acoustic parameters on bubble cloud dynamics in ultrasound tissue erosion (histotripsy)","volume":"122","author":"Xu","year":"2007","journal-title":"J Acoust Soc Am"},{"issue":"8","key":"10.1016\/j.eclinm.2026.103926_bib31","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1109\/TUFFC.2024.3409638","article-title":"In vivo cavitation-based aberration correction of Histotripsy in porcine liver","volume":"71","author":"Yeats","year":"2024","journal-title":"IEEE Trans Ultrason Ferroelectr Freq Control"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103926_bib32","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ultrasmedbio.2022.11.012","article-title":"Histotripsy bubble dynamics in elastic, anisotropic tissue-mimicking phantoms","volume":"49","author":"Elliott","year":"2023","journal-title":"Ultrasound Med Biol"},{"issue":"6","key":"10.1016\/j.eclinm.2026.103926_bib33","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/SLA.0000000000006720","article-title":"The #HOPE4LIVER single-arm pivotal trial for histotripsy of primary and metastatic liver tumors: one-year update of clinical outcomes","volume":"282","author":"Ziemlewicz","year":"2025","journal-title":"Ann Surg"},{"key":"10.1016\/j.eclinm.2026.103926_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.gassur.2025.102000","article-title":"The first international experience with histotripsy: a safety analysis of 230 cases","volume":"29","author":"Wehrle","year":"2025","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.eclinm.2026.103926_bib35","doi-asserted-by":"crossref","first-page":"Op2500550","DOI":"10.1200\/OP-25-00550","article-title":"Local tumor control of liver tumors after histotripsy: a preliminary national multicenter study","author":"Wehrle","year":"2025","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.eclinm.2026.103926_bib36","article-title":"First FDA approved experience with histotripsy for liver cancer management","volume":"19","author":"Chan","year":"2025","journal-title":"Int J Surg"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103926_bib37","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1097\/JS9.0000000000003856","article-title":"Prospective analysis on the outcomes of histotripsy for primary and metastatic liver tumors","volume":"112","author":"Chan","year":"2026","journal-title":"Int J Surg"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103926_bib38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103926_bib39","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jhep.2024.11.013","article-title":"Mastering the narrative: precision reporting of risk and oupcomes in liver transplantation","volume":"82","author":"de Goeij","year":"2025","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103926_bib40","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/LVT.0000000000000494","article-title":"Core outcome sets and benchmarking complications: defining best practices for standardized outcome reporting in liver transplantation","volume":"31","author":"Wehrle","year":"2025","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103926_bib41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/SLA.0000000000002794","article-title":"No surgical innovation without evaluation: evolution and further development of the IDEAL framework and recommendations","volume":"269","author":"Hirst","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.eclinm.2026.103926_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103926_bib43","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/wjs.12646","article-title":"Histotripsy of pancreatic cancer liver metastases: early outcomes and imaging findings","volume":"49","author":"Mabud","year":"2025","journal-title":"World J Surg"},{"issue":"11","key":"10.1016\/j.eclinm.2026.103926_bib44","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s00270-025-04183-8","article-title":"Histotripsy of liver metastases: Short-term safety and imaging findings","volume":"48","author":"Mabud","year":"2025","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.eclinm.2026.103926_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2025.109898","article-title":"The first full year of histotripsy for liver tumors: local tumor control and preliminary oncologic efficacy","volume":"191","author":"Wehrle","year":"2026","journal-title":"Surgery"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103926_bib46","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3390\/cancers17071100","article-title":"Histotripsy of liver tumors: patient selection, ethical discussions, and how we Do it","volume":"17","author":"Uysal","year":"2025","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103926_bib47","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103926_bib48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1148\/radiol.14132958","article-title":"Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update","volume":"273","author":"Ahmed","year":"2014","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.eclinm.2026.103926_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081085","article-title":"Current state of liver-directed therapies and combinatory approaches with systemic therapy in hepatocellular carcinoma (HCC)","volume":"11","author":"Viveiros","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103926_bib50","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/01.sla.0000118373.31781.f2","article-title":"Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients","volume":"239","author":"Curley","year":"2004","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.eclinm.2026.103926_bib51","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jvir.2025.06.002","article-title":"Hyperprogression and systemic metastasis of cholangiocarcinoma after histotripsy therapy","volume":"36","author":"Berman","year":"2025","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103926_bib52","doi-asserted-by":"crossref","DOI":"10.1080\/02656736.2025.2603108","article-title":"Vascular complications following histotripsy of hepatocellular carcinoma","volume":"42","author":"Wong","year":"2025","journal-title":"Int J Hyperthermia"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103926_bib53","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2214\/ajr.177.4.1770819","article-title":"Intrahepatic pseudoaneurysm complicating transjugular biopsy of the liver","volume":"177","author":"Roche","year":"2001","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"10.1016\/j.eclinm.2026.103926_bib54","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1111\/jth.15888","article-title":"Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: a prospective analysis of 302 procedures","volume":"20","author":"Bissonnette","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"17","key":"10.1016\/j.eclinm.2026.103926_bib55","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.21037\/atm-20-3928","article-title":"Hyperprogressive disease in advanced cancer patients with liver metastasis treated with PD-1 inhibitors: two case reports","volume":"8","author":"Lin","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.eclinm.2026.103926_bib56","article-title":"Hyperprogressive disease in patients suffering from solid malignancies treated by immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"12","author":"Zhao","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.eclinm.2026.103926_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100673","article-title":"Predicting hyperprogressive disease in patients with advanced hepatocellular carcinoma treated with anti-programmed cell death 1 therapy","volume":"31","author":"Zhang","year":"2021","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.eclinm.2026.103926_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvir.2026.108576","article-title":"Vascular injury after histotripsy: a case series of hemorrhage and pseudoaneurysm complications in human patients","volume":"37","author":"Breuer","year":"2026","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103926_bib59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.21037\/cco.2019.08.05","article-title":"Tailoring ablation strategies for colorectal liver metastases based upon rat sarcoma viral oncogene mutation status","volume":"8","author":"Calandri","year":"2019","journal-title":"Chin Clin Oncol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103926_bib60","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/02656736.2021.1912413","article-title":"Computed tomography-guided microwave ablation of perivascular liver metastases from colorectal cancer: a study of the ablation zone, feasibility, and safety","volume":"38","author":"Izaaryene","year":"2021","journal-title":"Int J Hyperthermia"},{"issue":"39","key":"10.1016\/j.eclinm.2026.103926_bib61","doi-asserted-by":"crossref","first-page":"66117","DOI":"10.18632\/oncotarget.19806","article-title":"Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases","volume":"8","author":"Shady","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.eclinm.2026.103926_bib62","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.2214\/AJR.18.20842","article-title":"Local tumor control and patient outcome using stereotactic body radiation therapy for hepatocellular carcinoma: iRECIST as a potential substitute for traditional criteria","volume":"213","author":"Vernuccio","year":"2019","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103926_bib63","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/1754-9485.13309","article-title":"Stereotactic ablative radiotherapy for hepatocellular carcinoma: a systematic review and meta-analysis of local control, survival and toxicity outcomes","volume":"65","author":"Shanker","year":"2021","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103926_bib64","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00000658-200204000-00004","article-title":"Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective","volume":"235","author":"Poon","year":"2002","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103926_bib65","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40164-025-00604-z","article-title":"Bridging therapy with histotripsy prior to liver transplantation for hepatocellular carcinoma: a first case report","volume":"14","author":"Uysal","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.eclinm.2026.103926_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1012799","article-title":"Spatiotemporal local and abscopal cell death and immune responses to histotripsy focused ultrasound tumor ablation","volume":"14","author":"Pepple","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103926_bib67","doi-asserted-by":"crossref","DOI":"10.1080\/02656736.2023.2297650","article-title":"Insights from in vivo preclinical cancer studies with histotripsy","volume":"41","author":"Worlikar","year":"2024","journal-title":"Int J Hyperthermia"},{"issue":"7","key":"10.1016\/j.eclinm.2026.103926_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071612","article-title":"Impact of histotripsy on development of intrahepatic metastases in a rodent liver tumor model","volume":"14","author":"Worlikar","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.eclinm.2026.103926_bib69","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1109\/TUFFC.2021.3100267","article-title":"Liver histotripsy mediated abscopal effect-case report","volume":"68","author":"Vidal-Jove","year":"2021","journal-title":"IEEE Trans Ultrason Ferroelectr Freq Control"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103926_bib70","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/00031348251371287","article-title":"Distant tumor response in the pelvis after histotripsy of a metastatic sarcoma of the liver in a patient with differentiated liposarcoma","volume":"92","author":"Ong","year":"2026","journal-title":"Am Surg"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026001744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026001744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:35:27Z","timestamp":1781670927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026001744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":70,"alternative-id":["S2589537026001744"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103926","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histotripsy for liver tumours: a systematic review and meta-analysis of current clinical evidence","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103926"}}